Longevity Venture Partners
VC Fund
Jerusalem, Israel
Longevity Venture Partners is an early-stage venture capital fund dedicated to nurturing promising entrepreneurs in the Silvertech, Healthcare, and Wellness sectors.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 15%
Last updated:
For AI agents: llms.txt
Industries Longevity Venture Partners invests in
Stages Longevity Venture Partners invests in
Countries Longevity Venture Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
2 more contacts available
Round size
- Seed
- $4M–$11M
- Pre-Seed
- $1.2M–$3.6M
Investment Focus
Industry
- Health Care 8 (62%)
- Medical Device 3 (23%)
- Health Diagnostics 3 (23%)
- Artificial Intelligence 3 (23%)
- Hospital 2 (15%)
Stage
- Seed 9 (69%)
- Pre-Seed 2 (15%)
- Series A 1 (8%)
Country
- Israel 7 (54%)
- United States 3 (23%)
- United Kingdom 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Jody Holtzman
Senior Managing Partner
|
Senior Managing Partner | Total investments: 0 | Find email | |
Ronald Wilheim
Founder
|
Founder | Total investments: 0 | Find email | |
Stephen Rosedale
Founder
|
Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Urologic Health
|
Urologic Health developing innovative solutions to improve bladder function diagnosis, monitoring, and treatment of urinary disorders. | $11M / Seed / May 14, 2026 | |
CustoMED
|
CustoMed transforms surgical planning and execution. It does this by converting medical imaging into 3D visualizations, planning procedures, and producing customized 3D-printed surgical solutions at scale in a matter of minutes, all while streamlining the process and providing surgical excellence. | $6M / Seed / Oct 29, 2025 | |
Sensifai Health
|
Sensifai Health operates as a bioconvergence start-up. Sensifai Health is an AI platform for preemptive health. | Seed / Oct 16, 2025 | |
Lembas
|
Lembas is a foodtech startup that has developed "GLP-1 Edge," a patent-pending peptide ingredient designed to naturally boost the GLP-1 hormone, which helps regulate appetite and metabolism for weight management. Using AI-driven discovery and licensed technology from Tel Aviv University, Lembas offers this peptide powder as abusiness-to-business ingredient for food and supplement brands, providing a science-backed, non-pharmaceutical alternative to weight loss drugs with no reported side effects | $3.6M / Pre-Seed / Jun 10, 2025 | |
Faireez
|
Optimizing tenants' lifestyle and convenience through enabling them with a hotel-like home cleaning service | $7.5M / Seed / Mar 06, 2025 | |
Exero Medical
|
Exero Medical is a medical device manufacturing company. It develops a biodegradable wireless sensor for early detection of anastomotic leaks following GI Surgery. Its system is designed to prevent complications by warning physicians of a potential leak, enabling early intervention.The company was founded in 2018 and is headquartered in OrYehuda, Israel. | $10M / Seed / Feb 13, 2025 | |
FertilAI
|
FertilAI is a healthcare company developing technologies that improve the success rate of fertility treatments, elevate the patient experience, and increase clinics ability to scale. The company’s AI algorithms automate the process and assist physicians in making the best clinical decisions during treatments. The algorithms are seamlesslyintegrated into the company’s Fertilane platform. This allows effective communication between clinics, doctors, and patients using doctor/patient apps and admin webapps tailor made for the fertility workflows. FertilAI is based in Israel and was founded by a collaboration of technology experts and leading REIs including Prof. Ariel Hourvitz, Dr. Ettie Maman, and Dr. Micha Baum. | $4.5M / Seed / Nov 20, 2024 | |
In-House Health
|
In-House Health is an AI-powered technical platform for modern nursing teams. | $4M / Seed / May 08, 2024 | |
|
FertilAI
|
FertilAI is a healthcare company developing technologies that improve the success rate of fertility treatments, elevate the patient experience, and increase clinics ability to scale. The company’s AI algorithms automate the process and assist physicians in making the best clinical decisions during treatments. The algorithms are seamlesslyintegrated into the company’s Fertilane platform. This allows effective communication between clinics, doctors, and patients using doctor/patient apps and admin webapps tailor made for the fertility workflows. FertilAI is based in Israel and was founded by a collaboration of technology experts and leading REIs including Prof. Ariel Hourvitz, Dr. Ettie Maman, and Dr. Micha Baum. | Seed / Oct 01, 2022 | |
Voxela, Inc.
|
We make aging beautiful. Voxela improves QOL and profitability of those eldercare businesses for a sustainable society. | Seed / Sep 23, 2022 | |
| See all 13 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Longevity Venture Partners invest in?
Longevity Venture Partners invests primarily in Health Care, Medical Device and Health Diagnostics startups, most often at Seed and Pre-Seed stage. Most of the 13 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Longevity Venture Partners's check size?
Longevity Venture Partners typically joins rounds of $4M–$11M at Seed and $1.2M–$3.6M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Longevity Venture Partners participates in.
How do I contact Longevity Venture Partners?
Public channels for Longevity Venture Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Longevity Venture Partners?
The team at Longevity Venture Partners includes Jody Holtzman (Senior Managing Partner), Ronald Wilheim (Founder) and Stephen Rosedale (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
